Free tool

Diagnostics stocks

We cover 14 companies grouped under the Diagnostics theme. The median market value in the group is $4.36B. Across the group, the median move over the past trading day is −0.20%. Price change over the past year runs from −11.1% to +142.7% across the middle 80 percent of the group, with a median of +12.9%.

Other lists in this group

Table

14 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
GHGuardant Health, Inc.$22.94BLarge cap+169.17%Oct 28, 2026
TEMTempus AI, Inc.$12.40BLarge cap−6.49%Nov 3, 2026
QGENQiagen N.V.$9.01BMid cap−9.65%Nov 4, 2026
QIA.DEQiagen N.V.$8.99BMid cap−6.73%Nov 4, 2026
ALQ.AXALS Limited$8.23BMid cap+22.07%Nov 23, 2026
6869.TSysmex Corporation$7.28BMid cap+3.66%Nov 4, 2026
BLLNBillionToOne, Inc.$4.54BMid cap−11.68%Nov 5, 2026
ADPTAdaptive Biotechnologies Corporation$4.18BMid cap+101.70%Nov 4, 2026
VCYTVeracyte, Inc. Common Stock$3.56BMid cap+54.81%Nov 3, 2026
GRALGRAIL, Inc.$3.55BMid cap+136.66%Nov 11, 2026
WGSGeneDx Holdings Corp.$2.69BMid cap−30.11%Oct 27, 2026
NEOGNeogen Corporation$2.54BMid cap+103.83%Oct 8, 2026
NEONeoGenomics, Inc.$2.26BMid cap+145.34%Oct 27, 2026
ALIF-B.STAddLife AB (publ)$2.08BMid cap−7.20%Oct 21, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse